218 related articles for article (PubMed ID: 18814214)
21. Antitumor drug ellipticine inhibits the activities of rat hepatic cytochromes P450.
Aimová D; Stiborová M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):437-40. PubMed ID: 16601806
[TBL] [Abstract][Full Text] [Related]
22. Influence of ginsenoside Rh1 and F1 on human cytochrome p450 enzymes.
Liu Y; Ma H; Zhang JW; Deng MC; Yang L
Planta Med; 2006 Feb; 72(2):126-31. PubMed ID: 16491447
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
Daniel WA; Haduch A; Wójcikowski J
Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
[TBL] [Abstract][Full Text] [Related]
24. The influence of CYP3A5 expression on the extent of hepatic CYP3A inhibition is substrate-dependent: an in vitro-in vivo evaluation.
Isoherranen N; Ludington SR; Givens RC; Lamba JK; Pusek SN; Dees EC; Blough DK; Iwanaga K; Hawke RL; Schuetz EG; Watkins PB; Thummel KE; Paine MF
Drug Metab Dispos; 2008 Jan; 36(1):146-54. PubMed ID: 17954524
[TBL] [Abstract][Full Text] [Related]
25. Interactions between cytochromes P450, glutathione S-transferases and Ghanaian medicinal plants.
Appiah-Opong R; Commandeur JN; Axson C; Vermeulen NP
Food Chem Toxicol; 2008 Dec; 46(12):3598-603. PubMed ID: 18822337
[TBL] [Abstract][Full Text] [Related]
26. Effect of sinomenine on human cytochrome P450 activity.
Yao YM; Cao W; Cao YJ; Cheng ZN; Ou-Yang DS; Liu ZQ; Zhou HH
Clin Chim Acta; 2007 Apr; 379(1-2):113-8. PubMed ID: 17292874
[TBL] [Abstract][Full Text] [Related]
27. Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design.
Perloff ES; Mason AK; Dehal SS; Blanchard AP; Morgan L; Ho T; Dandeneau A; Crocker RM; Chandler CM; Boily N; Crespi CL; Stresser DM
Xenobiotica; 2009 Feb; 39(2):99-112. PubMed ID: 19255936
[TBL] [Abstract][Full Text] [Related]
28. [Inhibitory effects of astragaloside IV on cytochrome P450 enzyme of rat liver microsomes].
Shan W; Zhang Y; Zhu J; Shao Q; Fan X
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):85-8. PubMed ID: 22741468
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo assessment of cytochrome P450-mediated herb-drug interaction of Ssang-hwa-tang.
Lee SY; Lee JY; Kang W; Kwon KI; Oh SJ; Ma JY; Kim SK
Food Chem; 2013 Jan; 136(2):450-7. PubMed ID: 23122083
[TBL] [Abstract][Full Text] [Related]
30. Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction.
Kumar G; Lau H; Laskin O
Cancer Chemother Pharmacol; 2009 May; 63(6):1171-5. PubMed ID: 19030860
[TBL] [Abstract][Full Text] [Related]
31. Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine.
Arbus C; Benyamina A; Llorca PM; Baylé F; Bromet N; Massiere F; Garay RP; Hameg A
Eur J Pharm Sci; 2007 Dec; 32(4-5):357-66. PubMed ID: 17951033
[TBL] [Abstract][Full Text] [Related]
32. Characterization of diuron N-demethylation by mammalian hepatic microsomes and cDNA-expressed human cytochrome P450 enzymes.
Abass K; Reponen P; Turpeinen M; Jalonen J; Pelkonen O
Drug Metab Dispos; 2007 Sep; 35(9):1634-41. PubMed ID: 17576805
[TBL] [Abstract][Full Text] [Related]
33. An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes.
Nassar AE; King I; Paris BL; Haupt L; Ndikum-Moffor F; Campbell R; Usuki E; Skibbe J; Brobst D; Ogilvie BW; Parkinson A
Drug Metab Dispos; 2009 Sep; 37(9):1922-30. PubMed ID: 19520774
[TBL] [Abstract][Full Text] [Related]
34. Organophosphorothionate pesticides inhibit the bioactivation of imipramine by human hepatic cytochrome P450s.
Di Consiglio E; Meneguz A; Testai E
Toxicol Appl Pharmacol; 2005 Jun; 205(3):237-46. PubMed ID: 15922009
[TBL] [Abstract][Full Text] [Related]
35. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.
Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S
Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737
[TBL] [Abstract][Full Text] [Related]
36. Effect of vanillin and ethyl vanillin on cytochrome P450 activity in vitro and in vivo.
Chen XM; Wei M; Zhang HM; Luo CH; Chen YK; Chen Y
Food Chem Toxicol; 2012 Jun; 50(6):1897-901. PubMed ID: 22450566
[TBL] [Abstract][Full Text] [Related]
37. Effect of sodium ozagrel on the activity of rat CYP2D6.
Wu H; Yu W; Huang L; Wang J; Tang X; Yang W; Liu Y; Yu H; Zhu D
Eur J Pharmacol; 2007 Nov; 573(1-3):55-9. PubMed ID: 17651725
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of para toluene-sulfonamide metabolism and effect with regard to CYP isoforms, P-glycoprotein, and drug interactions.
Zhou JQ; Tang ZQ; Zhang JN
Pharmazie; 2006 Oct; 61(10):869-73. PubMed ID: 17069428
[TBL] [Abstract][Full Text] [Related]
39. Induction and inhibition of cytochrome P450-dependent monooxygenases of rats by fungicide bitertanol.
Chan PK; Lu SY; Liao JW; Wei CF; Tsai Y; Ueng TH
Food Chem Toxicol; 2006 Dec; 44(12):2047-57. PubMed ID: 16971034
[TBL] [Abstract][Full Text] [Related]
40. Impact of chrysosplenetin on the pharmacokinetics and anti-malarial efficacy of artemisinin against Plasmodium berghei as well as in vitro CYP450 enzymatic activities in rat liver microsome.
Wei S; Ji H; Yang B; Ma L; Bei Z; Li X; Dang H; Yang X; Liu C; Wu X; Chen J
Malar J; 2015 Nov; 14():432. PubMed ID: 26537009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
